Gene Expression Signature of Acquired Chemoresistance in Neuroblastoma Cells
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Drug resistance of childhood cancer neuroblastoma is a serious clinical problem. Patients with relapsed disease have a poor prognosis despite intense treatment. In the present study, we aimed to identify chemoresistance gene expression signatures in vincristine resistant neuroblastoma cells. We found that vincristine-resistant neuroblastoma cells formed larger clones and survived under reduced serum conditions as compared with non-resistant parental cells. To identify the possible mechanisms underlying vincristine resistance in neuroblastoma cells, we investigated the expression profiles of genes known to be involved in cancer drug resistance. This specific gene expression patterns could predict the behavior of a tumor in response to chemotherapy and for predicting the prognosis of high-risk neuroblastoma patients. Our signature could help chemoresistant neuroblastoma patients in avoiding useless and harmful chemotherapy cycles.
SAP30, an oncogenic driver of progression, poor survival, and drug resistance in neuroblastoma.
Prathipati P, Pathania A, Chaturvedi N, Gupta S, Byrareddy S, Coulter D Mol Ther Nucleic Acids. 2024; 35(2):101543.
PMID: 38817681 PMC: 11137595. DOI: 10.1016/j.omtn.2022.03.014.
Italia M, Wertheim K, Taschner-Mandl S, Walker D, Dercole F Cancers (Basel). 2023; 15(7).
PMID: 37046647 PMC: 10093626. DOI: 10.3390/cancers15071986.
Cathepsin L promotes chemresistance to neuroblastoma by modulating serglycin.
Du X, Ding L, Huang S, Li F, Yan Y, Tang R Front Pharmacol. 2022; 13:920022.
PMID: 36133820 PMC: 9484481. DOI: 10.3389/fphar.2022.920022.
Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Treatment Option for Neuroblastoma.
Muller M, Rosch L, Najafi S, Gatzweiler C, Ridinger J, Gerloff X Cancers (Basel). 2021; 13(17).
PMID: 34503286 PMC: 8431508. DOI: 10.3390/cancers13174476.